Literature DB >> 3536743

Stage-specific and species-specific antigens of Plasmodium vivax and Plasmodium ovale defined by monoclonal antibodies.

P M Andrysiak, W E Collins, G H Campbell.   

Abstract

Monoclonal antibodies (MAbs) were produced against the asexual blood stages of Plasmodium vivax and Plasmodium ovale and used to define antigens of plasmodial parasites in an indirect fluorescent antibody assay. The anti-P. vivax MAbs produced two distinct patterns in the indirect fluorescent antibody assay. Four patterns were found with the anti-P. ovale MAbs. Species-specific epitopes were defined for P. vivax and P. ovale; epitopes shared among all four species of human malaria parasites were also defined. Some of the anti-P. vivax MAbs reacted only with mature stages, and others reacted with all asexual stages. No asexual blood-stage specificity could be found with the anti-P. ovale antibodies. Five of the anti-P. vivax MAbs and three of the anti-P. ovale MAbs also reacted with sporozoites.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3536743      PMCID: PMC260212          DOI: 10.1128/iai.54.3.609-612.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Two Plasmodium falciparum merozoite surface polypeptides share epitopes with a single Mr 185 000 parasite glycoprotein.

Authors:  R F Howard; H A Stanley; G H Campbell; S G Langreth; R T Reese
Journal:  Mol Biochem Parasitol       Date:  1985-10       Impact factor: 1.759

2.  PLASMODIUM VIVAX CHESSON STRAIN.

Authors:  F C Ehrman; J M Ellis; M D Young
Journal:  Science       Date:  1945-04-13       Impact factor: 47.728

3.  Concentration of Plasmodium ovale- and Plasmodium vivax-infected erythrocytes from nonhuman primate blood using Percoll gradients.

Authors:  P M Andrysiak; W E Collins; G H Campbell
Journal:  Am J Trop Med Hyg       Date:  1986-03       Impact factor: 2.345

4.  Epitope map and processing scheme for the 195,000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene.

Authors:  J A Lyon; R H Geller; J D Haynes; J D Chulay; J L Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  Monoclonal antibodies to stage-specific, species-specific, and cross-reactive antigens of the rodent malarial parasite, Plasmodium yoelii.

Authors:  D W Taylor; K J Kim; P A Munoz; C B Evans; R Asofsky
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

6.  The indirect fluorescent antibody test for the detection of occult malaria in blood donors.

Authors:  A J Sulzer; M Wilson
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

7.  Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite.

Authors:  R R Freeman; A J Trejdosiewicz; G A Cross
Journal:  Nature       Date:  1980-03-27       Impact factor: 49.962

8.  Observations on the infectivity of two strains of Plasmodium vivax from Vietnamese refugees to Aotus monkeys and anopheline mosquitoes.

Authors:  W E Collins; M Warren; J C Skinner; A Y Huong; P Nguyen-Dinh
Journal:  J Parasitol       Date:  1983-08       Impact factor: 1.276

9.  Studies on the Uganda I/CDC strain of Plasmodium malariae in bolivian Aotus monkeys and various anophelines.

Authors:  W E Collins; I K Schwartz; J C Skinner; J R Broderson
Journal:  J Parasitol       Date:  1984-10       Impact factor: 1.276

10.  Surface antigens of malaria merozoites. A high molecular weight precursor is processed to an 83,000 mol wt form expressed on the surface of Plasmodium falciparum merozoites.

Authors:  R R Freeman; A A Holder
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Multispecies Plasmodium infections of humans.

Authors:  F E McKenzie; W H Bossert
Journal:  J Parasitol       Date:  1999-02       Impact factor: 1.276

Review 2.  Plasmodium ovale: parasite and disease.

Authors:  William E Collins; Geoffrey M Jeffery
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.